BSEN761
Tinnitus
PreclinicalActive
Key Facts
About Bsense Bio Therapeutics
Dual‑target small molecules for non‑opioid pain, tinnitus and itch relief.
View full company profileOther Tinnitus Drugs
| Drug | Company | Phase |
|---|---|---|
| Lenire | Neuromod Devices | Approved |
| Advanced Tinnitus Management | Starkey | Development/Commercial |